|
|
||||||||
The Journal of Immunology, Vol 157, Issue 6 2549-2554, Copyright © 1996 by American Association of Immunologists
ARTICLES |
R Savedra Jr, RL Delude, RR Ingalls, MJ Fenton and DT Golenbock
The Maxwell Finland Laboratory for Infectious Diseases, Department of Medicine, Boston City Hospital, MA 02118, USA.
Phagocytic leukocytes respond to a variety of bacterial products including Gram-negative bacterial LPS and mycobacterial lipoarabinomannan (LAM). Anti-CD14 mAbs have been shown to block LPS and LAM activation of myeloid cells, suggesting that CD14 is required for cellular recognition of both ligands. Activation of undifferentiated promonomyelocytic THP-1 cells with LAM or LPS under serum-free conditions was enhanced in the presence of recombinant soluble CD14 (rsCD14). LPS binding protein (LBP), which is present in normal serum, further enhanced the sensitivity of undifferentiated THP- 1 cells to both ligands even in the absence of rsCD14. Although CD14- transfected Chinese hamster ovary and human HT1080 fibrosarcoma cell lines can be activated by LPS, neither cell line was activated by LAM. Furthermore, U373 astrocytoma cells, which respond to LPS using sCD14 and LBP, failed to be activated by LAM in the presence of rsCD14 and rLBP. We then tested the effects of lipid IVA and Rhodobacter sphaeroides lipid A, compounds that function as endotoxin inhibitors in human cells by interacting with a molecule thought to be a CD14- dependent LPS signal transducer. Both lipid IVA and R. sphaeroides lipid A inhibited the effects of LPS and LAM in THP-1 cells. Thus, the LPS and LAM receptors share CD14, LBP, and a putative endotoxin antagonist-inhibitable signal transducing component. However, the LAM signaling system appears to require an additional receptor component whose expression is restricted to cells of hemopoietic origin.
This article has been cited by other articles:
![]() |
A. E. Medvedev, W. Piao, J. Shoenfelt, S. H. Rhee, H. Chen, S. Basu, L. M. Wahl, M. J. Fenton, and S. N. Vogel Role of TLR4 Tyrosine Phosphorylation in Signal Transduction and Endotoxin Tolerance J. Biol. Chem., June 1, 2007; 282(22): 16042 - 16053. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Wang, R. M. McLoughlin, B. A. Cobb, M. Charrel-Dennis, K. J. Zaleski, D. Golenbock, A. O. Tzianabos, and D. L. Kasper A bacterial carbohydrate links innate and adaptive responses through Toll-like receptor 2 J. Exp. Med., December 25, 2006; 203(13): 2853 - 2863. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. E. Medvedev, I. Sabroe, J. D. Hasday, and S. N. Vogel Invited review: Tolerance to microbial TLR ligands: molecular mechanisms and relevance to disease Innate Immunity, June 1, 2006; 12(3): 133 - 150. [Abstract] [PDF] |
||||
![]() |
P. T. Liu, S. R. Krutzik, J. Kim, and R. L. Modlin Cutting Edge: All-trans Retinoic Acid Down-Regulates TLR2 Expression and Function J. Immunol., March 1, 2005; 174(5): 2467 - 2470. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. W. Wieland, S. Knapp, S. Florquin, A. F. de Vos, K. Takeda, S. Akira, D. T. Golenbock, A. Verbon, and T. van der Poll Non-Mannose-capped Lipoarabinomannan Induces Lung Inflammation via Toll-like Receptor 2 Am. J. Respir. Crit. Care Med., December 15, 2004; 170(12): 1367 - 1374. [Abstract] [Full Text] [PDF] |
||||
![]() |
R Arroyo-Espliguero, P Avanzas, S Jeffery, and J C Kaski CD14 and toll-like receptor 4: a link between infection and acute coronary events? Heart, September 1, 2004; 90(9): 983 - 988. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kato, T. Ogasawara, T. Homma, H. Saito, and K. Matsumoto Lipopolysaccharide-Binding Protein Critically Regulates Lipopolysaccharide-Induced IFN-{beta} Signaling Pathway in Human Monocytes J. Immunol., May 15, 2004; 172(10): 6185 - 6194. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Vignal, Y. Guerardel, L. Kremer, M. Masson, D. Legrand, J. Mazurier, and E. Elass Lipomannans, But Not Lipoarabinomannans, Purified from Mycobacterium chelonae and Mycobacterium kansasii Induce TNF-{alpha} and IL-8 Secretion by a CD14-Toll-Like Receptor 2-Dependent Mechanism J. Immunol., August 15, 2003; 171(4): 2014 - 2023. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Muroi, T. Ohnishi, S. Azumi-Mayuzumi, and K.-i. Tanamoto Lipopolysaccharide-Mimetic Activities of a Toll-Like Receptor 2-Stimulatory Substance(s) in Enterobacterial Lipopolysaccharide Preparations Infect. Immun., June 1, 2003; 71(6): 3221 - 3226. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Iovine, J. Eastvold, P. Elsbach, J. P. Weiss, and T. L. Gioannini The Carboxyl-terminal Domain of Closely Related Endotoxin-binding Proteins Determines the Target of Protein-Lipopolysaccharide Complexes J. Biol. Chem., March 1, 2002; 277(10): 7970 - 7978. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. H. Diks, S. J.H. van Deventer, and M. P. Peppelenbosch Invited review: Lipopolysaccharide recognition, internalisation, signalling and other cellular effects Innate Immunity, October 1, 2001; 7(5): 335 - 348. [Abstract] [PDF] |
||||
![]() |
A. E. Medvedev, P. Henneke, A. Schromm, E. Lien, R. Ingalls, M. J. Fenton, D. T. Golenbock, and S. N. Vogel Induction of Tolerance to Lipopolysaccharide and Mycobacterial Components in Chinese Hamster Ovary/CD14 Cells Is Not Affected by Overexpression of Toll-Like Receptors 2 or 4 J. Immunol., August 15, 2001; 167(4): 2257 - 2267. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Sugawara, S. Yang, K. Iki, J. Hatakeyama, R. Tamai, O. Takeuchi, S. Akashi, T. Espevik, S. Akira, and H. Takada Monocytic Cell Activation by Nonendotoxic Glycoprotein from Prevotella intermedia ATCC 25611 Is Mediated by Toll-Like Receptor 2 Infect. Immun., August 1, 2001; 69(8): 4951 - 4957. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. P. Juffermans, P. E. P. Dekkers, A. Verbon, P. Speelman, S. J. H. van Deventer, and T. van der Poll Concurrent Upregulation of Urokinase Plasminogen Activator Receptor and CD11b during Tuberculosis and Experimental Endotoxemia Infect. Immun., August 1, 2001; 69(8): 5182 - 5185. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. R. Ingalls, E. Lien, and D. T. Golenbock Membrane-Associated Proteins of a Lipopolysaccharide-Deficient Mutant of Neisseria meningitidis Activate the Inflammatory Response through Toll-Like Receptor 2 Infect. Immun., April 1, 2001; 69(4): 2230 - 2236. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kielian, B. Barry, and W. F. Hickey CXC Chemokine Receptor-2 Ligands Are Required for Neutrophil-Mediated Host Defense in Experimental Brain Abscesses1 J. Immunol., April 1, 2001; 166(7): 4634 - 4643. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. K. Means, B. W. Jones, A. B. Schromm, B. A. Shurtleff, J. A. Smith, J. Keane, D. T. Golenbock, S. N. Vogel, and M. J. Fenton Differential Effects of a Toll-Like Receptor Antagonist on Mycobacterium tuberculosis-Induced Macrophage Responses J. Immunol., March 15, 2001; 166(6): 4074 - 4082. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. R. Strohmeier, J. H. Walsh, E. S. Klings, H. W. Farber, W. W. Cruikshank, D. M. Center, and M. J. Fenton Lipopolysaccharide Binding Protein Potentiates Airway Reactivity in a Murine Model of Allergic Asthma J. Immunol., February 1, 2001; 166(3): 2063 - 2070. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Sugiyama and S. D. Wright Soluble CD14 Mediates Efflux of Phospholipids from Cells J. Immunol., January 15, 2001; 166(2): 826 - 831. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. H. Flo, L. Ryan, L. Kilaas, G. Skjak-Brak, R. R. Ingalls, A. Sundan, D. T. Golenbock, and T. Espevik Involvement of CD14 and beta 2-Integrins in Activating Cells with Soluble and Particulate Lipopolysaccharides and Mannuronic Acid Polymers Infect. Immun., December 1, 2000; 68(12): 6770 - 6776. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J. Moore, L. P. Andersson, R. R. Ingalls, B. G. Monks, R. Li, M. A. Arnaout, D. T. Golenbock, and M. W. Freeman Divergent Response to LPS and Bacteria in CD14-Deficient Murine Macrophages J. Immunol., October 15, 2000; 165(8): 4272 - 4280. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. R. Ingalls, E. Lien, and D. T. Golenbock Differential roles of TLR2 and TLR4 in the host response to Gram-negative bacteria: lessons from a lipopolysaccharide-deficient mutant of Neisseria meningitidis Innate Immunity, October 1, 2000; 6(5): 411 - 415. [Abstract] [PDF] |
||||
![]() |
C. Astarie-Dequeker, J. Nigou, G. Puzo, and I. Maridonneau-Parini Lipoarabinomannans Activate the Protein Tyrosine Kinase Hck in Human Neutrophils Infect. Immun., August 1, 2000; 68(8): 4827 - 4830. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. P. JUFFERMANS, A. VERBON, J. T. BELISLE, P. J. HILL, P. SPEELMAN, S. J. H. van DEVENTER, and T. van der POLL Mycobacterial Lipoarabinomannan Induces an Inflammatory Response in the Mouse Lung . A Role for Interleukin-1 Am. J. Respir. Crit. Care Med., August 1, 2000; 162(2): 486 - 489. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hirschfeld, Y. Ma, J. H. Weis, S. N. Vogel, and J. J. Weis Cutting Edge: Repurification of Lipopolysaccharide Eliminates Signaling Through Both Human and Murine Toll-Like Receptor 2 J. Immunol., July 15, 2000; 165(2): 618 - 622. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. Orr and P. Tobias LPS and LAM activation of the U373 astrocytoma cell line: Differential requirement for CD14 Innate Immunity, June 1, 2000; 6(3): 215 - 222. [Abstract] [PDF] |
||||
![]() |
K. Imai, A. Takeshita, and S. Hanazawa Transforming Growth Factor-beta Inhibits Lipopolysaccharide-Stimulated Expression of Inflammatory Cytokines in Mouse Macrophages through Downregulation of Activation Protein 1 and CD14 Receptor Expression Infect. Immun., May 1, 2000; 68(5): 2418 - 2423. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. K. Means, E. Lien, A. Yoshimura, S. Wang, D. T. Golenbock, and M. J. Fenton The CD14 Ligands Lipoarabinomannan and Lipopolysaccharide Differ in Their Requirement for Toll-Like Receptors J. Immunol., December 15, 1999; 163(12): 6748 - 6755. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Underhill, A. Ozinsky, K. D. Smith, and A. Aderem Toll-like receptor-2 mediates mycobacteria-induced proinflammatory signaling in macrophages PNAS, December 7, 1999; 96(25): 14459 - 14463. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Lien, T. J. Sellati, A. Yoshimura, T. H. Flo, G. Rawadi, R. W. Finberg, J. D. Carroll, T. Espevik, R. R. Ingalls, J. D. Radolf, et al. Toll-like Receptor 2 Functions as a Pattern Recognition Receptor for Diverse Bacterial Products J. Biol. Chem., November 19, 1999; 274(47): 33419 - 33425. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. K. Means, S. Wang, E. Lien, A. Yoshimura, D. T. Golenbock, and M. J. Fenton Human Toll-Like Receptors Mediate Cellular Activation by Mycobacterium tuberculosis J. Immunol., October 1, 1999; 163(7): 3920 - 3927. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Adachi, C. Satokawa, M. Saeki, N. Ohno, H. Tamura, S. Tanaka, and T. Yadomae Inhibition by a CD14 monoclonal antibody of lipopolysaccharide binding to murine macrophages Innate Immunity, June 1, 1999; 5(3): 139 - 146. [Abstract] [PDF] |
||||
![]() |
J. Talkington and S. P. Nickell Borrelia burgdorferi Spirochetes Induce Mast Cell Activation and Cytokine Release Infect. Immun., March 1, 1999; 67(3): 1107 - 1115. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Jason, L. Archibald, L. C. McDonald, W. M. Hart, S. Rheanppumikankit, S. Tansuphwaswadikul, M. G. Byrd, J. Larned, A. Han, T. A. Green, et al. Immune Determinants of Organism and Outcome in Febrile Hospitalized Thai Patients with Bloodstream Infections Clin. Vaccine Immunol., January 1, 1999; 6(1): 73 - 78. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. R. Ingalls, B. G. Monks, R. Savedra Jr., W. J. Christ, R. L. Delude, A. E. Medvedev, T. Espevik, and D. T. Golenbock CD11/CD18 and CD14 Share a Common Lipid A Signaling Pathway J. Immunol., November 15, 1998; 161(10): 5413 - 5420. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. L. Collins, U. E. Schaible, and S. H. E. Kaufmann Early IL-4 Induction in Bone Marrow Lymphoid Precursor Cells by Mycobacterial Lipoarabinomannan J. Immunol., November 15, 1998; 161(10): 5546 - 5554. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Bliss Jr., D. T. Golenbock, S. Keates, J. K. Linevsky, and C. P. Kelly Helicobacter pylori Lipopolysaccharide Binds to CD14 and Stimulates Release of Interleukin-8, Epithelial Neutrophil-Activating Peptide 78, and Monocyte Chemotactic Protein 1 by Human Monocytes Infect. Immun., November 1, 1998; 66(11): 5357 - 5363. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Yu, E. Soprana, G. Cosentino, M. Volta, H. S. Lichenstein, G. Viale, and D. Vercelli Soluble CD141-152 Confers Responsiveness to Both Lipoarabinomannan and Lipopolysaccharide in a Novel HL-60 Cell Bioassay J. Immunol., October 15, 1998; 161(8): 4244 - 4251. [Abstract] [Full Text] [PDF] |
||||
![]() |
P.-y. Wang, R. L. Kitchens, and R. S. Munford Phosphatidylinositides Bind to Plasma Membrane CD14 and Can Prevent Monocyte Activation by Bacterial Lipopolysaccharide J. Biol. Chem., September 18, 1998; 273(38): 24309 - 24313. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. Delude, A. Yoshimura, R. R. Ingalls, and D. T. Golenbock Construction of a Lipopolysaccharide Reporter Cell Line and Its Use in Identifying Mutants Defective in Endotoxin, But Not TNF-{alpha}, Signal Transduction J. Immunol., September 15, 1998; 161(6): 3001 - 3009. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Lien, P. Aukrust, A. Sundan, F. Muller, S. S. Froland, and T. Espevik Elevated Levels of Serum-Soluble CD14 in Human Immunodeficiency Virus Type 1 (HIV-1) Infection: Correlation to Disease Progression and Clinical Events Blood, September 15, 1998; 92(6): 2084 - 2092. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Zabaleta, M. Arias, J. R. Maya, and L. F. García Diminished Adherence and/or Ingestion of Virulent Mycobacterium tuberculosis by Monocyte-Derived Macrophages from Patients with Tuberculosis Clin. Vaccine Immunol., September 1, 1998; 5(5): 690 - 694. [Abstract] [Full Text] |
||||
![]() |
T. A. Lodie, M. Reiner, S. Coniglio, G. Viglianti, and M. J. Fenton Both PU.1 and Nuclear Factor-{kappa}B Mediate Lipopolysaccharide-Induced HIV-1 Long Terminal Repeat Transcription in Macrophages J. Immunol., July 1, 1998; 161(1): 268 - 276. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J. Sellati, D. A. Bouis, R. L. Kitchens, R. P. Darveau, J. Pugin, R. J. Ulevitch, S. C. Gangloff, S. M. Goyert, M. V. Norgard, and J. D. Radolf Treponema pallidum and Borrelia burgdorferi Lipoproteins and Synthetic Lipopeptides Activate Monocytic Cells via a CD14-Dependent Pathway Distinct from That Used by Lipopolysaccharide J. Immunol., June 1, 1998; 160(11): 5455 - 5464. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Wooten, T. B. Morrison, J. H. Weis, S. D. Wright, R. Thieringer, and J. J. Weis The Role of CD14 in Signaling Mediated by Outer Membrane Lipoproteins of Borrelia burgdorferi J. Immunol., June 1, 1998; 160(11): 5485 - 5492. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Berntzen, T. H. Flo, A. Medvedev, L. Kilaas, G. Skjåk-Bræk, A. Sundan, and T. Espevik Clin. Vaccine Immunol., May 1, 1998; 5(3): 355 - 361. [Abstract] |
||||
![]() |
A. E. Medvedev, T. Flo, R. R. Ingalls, D. T. Golenbock, G. Teti, S. N. Vogel, and T. Espevik Involvement of CD14 and Complement Receptors CR3 and CR4 in Nuclear Factor-{kappa}B Activation and TNF Production Induced by Lipopolysaccharide and Group B Streptococcal Cell Walls J. Immunol., May 1, 1998; 160(9): 4535 - 4542. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Dziarski, R. I. Tapping, and P. S. Tobias Binding of Bacterial Peptidoglycan to CD14 J. Biol. Chem., April 10, 1998; 273(15): 8680 - 8690. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Ernst Macrophage Receptors for Mycobacterium tuberculosis Infect. Immun., April 1, 1998; 66(4): 1277 - 1281. [Full Text] [PDF] |
||||
![]() |
J. Bernardo, A. M. Billingslea, R. L. Blumenthal, K. F. Seetoo, E. R. Simons, and M. J. Fenton Differential Responses of Human Mononuclear Phagocytes to Mycobacterial Lipoarabinomannans: Role of CD14 and the Mannose Receptor Infect. Immun., January 1, 1998; 66(1): 28 - 35. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |